Alumis, Inc. (ALMS)
6.56
-0.50
(-7.08%)
USD |
NASDAQ |
Oct 13, 16:00
6.64
+0.08
(+1.22%)
After-Hours: 07:12
Alumis EPS Diluted (TTM) : -3.809 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.809 |
| March 31, 2026 | -1.921 |
| December 31, 2025 | -3.000 |
| September 30, 2025 | -3.855 |
| June 30, 2025 | -4.502 |
| March 31, 2025 | -6.315 |
| December 31, 2024 | -5.453 |
| Date | Value |
|---|---|
| September 30, 2024 | -4.470 |
| June 30, 2024 | -3.595 |
| March 31, 2024 | -3.256 |
| December 31, 2023 | -2.990 |
| September 30, 2023 | -2.232 |
| June 30, 2023 | -1.395 |
| March 31, 2023 | -0.6949 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Johnson & Johnson | 6.592 |
| Corcept Therapeutics, Inc. | 0.4187 |
| Aclaris Therapeutics, Inc. | -0.5852 |
| BioAge Labs, Inc. | -2.387 |
| ANI Pharmaceuticals, Inc. | 4.632 |